Effects of Posttrial Antihypertensive Drugs on Morbidity and Mortality: Findings from 15-Year Passive Follow-Up after ALLHAT Ended

BACKGROUND: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) ended in 2002, but it is important to study its long-term outcomes during the posttrial period by incorporating posttrial antihypertensive medication uses in the analysis. PURPOSES: The primary aim is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xianglin L., Simpson, Lara M., Tandy, Brian C., Bettencourt, Judy, Davis, Barry R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677412/
https://www.ncbi.nlm.nih.gov/pubmed/34925915
http://dx.doi.org/10.1155/2021/2261144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677412/
https://www.ncbi.nlm.nih.gov/pubmed/34925915
http://dx.doi.org/10.1155/2021/2261144

Ejemplares similares